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Background: Conflicting results regarding changes inmucosal IgA production or in the proportions of IgA plasma cells in
the small and large intestines during HIV-infection have been previously reported. Except in individuals repeatedly exposed
to HIV-1 but yet remaining uninfected, HIV-specific IgAs are frequently absent inmucosal secretions fromHIV-infected
patients. However, little is known about the organization and functionality of mucosal B-cell follicles in acute HIV/SIV infection
duringwhich a T-dependent IgA response should have been initiated. In the present study, we evaluated changes in B-cell
and T-cell subsets as well as the extent of apoptosis and class-specific plasma cells in Peyer’s Patches, isolated lymphoid
follicles, and lamina propria. Plasma levels of IgA, BAFF and APRIL were also determined.
Results: Plasma IgA level was reduced by 46% by 28 days post infection (dpi), and no IgA plasma cells were foundwithin
germinal centers of Peyer’s Patches and isolated lymphoid follicles. This lack of a T-dependent IgA response occurs although
germinal centers remained functional with no sign of follicular damage, while a prolonged survival of follicular CD4+ T-cells
and normal generation of IgG plasma cells is observed. Whereas the average plasma BAFF level was increased by 4.5-fold
and total plasma cells were 1.7 to 1.9-foldmore numerous in the lamina propria, the relative proportion of IgA plasma cells in
this effector site was reduced by 19% (duodemun) to 35% (ileum) at 28 dpi.
Conclusion:Our data provide evidence that SIV is unable to initiate a T-dependent IgA response during the acute phase of
infection and favors the production of IgG (ileum) or IgM (duodenum) plasma cells at the expense of IgA plasma cells.
Therefore, an early and generalized default in IgA production takes place during the acute of phase of HIV/SIV infection,
whichmight impair not only the virus-specific antibody response but also IgA responses to other pathogens and vaccines as
well. Understanding themechanisms that impair IgA production during acute HIV/SIV infection is crucial to improve virus-
specific response inmucosa and control microbial translocation.
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The gastrointestinal tract is a privileged site for both HIV-
1/SIV replication and extensive CD4+ T-cell depletion at
all stages of the pathogenic infection [1,2]. One of the
physiological roles of the gastrointestinal tract in immuno-
logical defense is to produce large amounts of IgA that
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reproduction in any medium, provided the orpathogens [3]. IgA are produced from plasmablasts
(plasma cell precursors) generated in germinal centers
(GC) of Peyer’s patches (PP) and mesenteric lymph nodes
that constitute major inductive sites of T-dependent IgA
antibodies. Both T-cell help and local production of cyto-
kines participate in T-dependent IgA production [4-7].
IgA class switching also occurs in isolated lymphoid folli-
cles (ILF), which have a cellular composition similar to
PP-associated follicles and constitute dynamic lymphoid
structures that develop in response to chronic infection or
inflammation [8-10]. In addition to the canonical TGFβ1
IgA switch factor, IL10, IL21, B-cell Activating Factor of theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(APRIL) are also key factors involved in both T-dependent
and T-independent immunoglobulin class switching [9,11].
These latter cytokines most likely account for IgA produc-
tion in children with defective CD40L [12,13]. In contrast
to humans, only one IgA isotype is found in macaques,
with a structure resembling that of human IgA2 [14,15].
Although conflicting results exist concerning the pres-
ence of HIV-specific IgA in genital secretions of women
repeatedly exposed to HIV-1 but yet remaining uninfected
[16-19], HIV-specific IgA are generally absent or present
at very low levels in plasma and mucosal secretions of
chronically HIV-infected patients [20-24]. In contrast to
other encountered mucosal microbial infections, HIV-1
infection preferentially leads to potent IgG responses in
any body fluids. Decreased levels of IgA in intestinal fluids
associates with reduced proportions of IgA plasma cells
within the lamina propria (LP) of the duodenum and
colon of chronically HIV-infected patients [25]. In AIDS
patients, depletion of IgA plasma cells in the small intes-
tine also correlates with decreased secretion of IgA in sal-
iva [22]. In supernatants of short-term cultured duodenal
biopsies from SIV-infected macaques, Schafer at al.
described a decrease in total IgA and a lack of SIV-specific
IgA for up to 6 months post-infection [26]. However,
measuring HIV/SIV-specific and total antibodies in intes-
tinal and vaginal secretions by ELISA constitutes a tech-
nical challenge [27], likely contributing to conflicting
results. Moreover, IgA secretion is highly dependent on
the integrity of epithelial cells, which is frequently
impaired during acute and chronic HIV/SIV infections
[28-30]. Overall, the lack of IgA in intestinal fluids of
chronically HIV-infected patients or SIV-infected maca-
ques can be explained by a default in shedding, impaired
homing of IgA plasmablasts to LP or their impaired ter-
minal differentiation into plasma cells. In addition, recent
data of Xu et al. suggested that an impaired isotype
switching towards IgA occurs in inductive sites [31], pre-
venting the generation of IgA plasmablasts.
Here, we have examined changes in the proportions
of IgA vs. IgG and IgM plasma cells within the in-
ductive sites (germinal centers of B-cell follicles) and
effector site (LP) of the small intestine (duodenum
and terminal ileum) of acutely SIV-infected macaques
to determine at which step the generation of IgA
plasma cells was impaired. Our data reveal a progres-
sive decrease in plasma IgA after SIV infection, asso-
ciated with a lack of IgA plasma cells within GC of
PP and isolated lymphoid follicles while functional
GC can still give rise to IgG plasma cells. Whereas
the densities of total plasma cells increased in the LP,
the relative proportion of IgA plasma cells decreased.
Altogether, these findings suggest that SIV is unable
to initiate a T-dependent IgA response during theacute phase of SIV infection despite prolonged sur-
vival of follicular CD4+ T-cells.
Results
Increased B-cell homing to the intestinal mucosa during
the acute phase of infection
Both changes in levels of plasma viral load and CD4+ T-cell
count followed similar kinetics and range in all macaques.
By 11–12 dpi, plasma viral load peaked with a median value
of 7.36 log10 SIV RNA copies/ml before decreasing to 5.78
log10 SIV RNA copies/ml on 28 dpi (Figure 1A). As com-
pared to its value before infection, the median blood CD4+
T-cell count reached its lowest value on 11–12 dpi (76.9%
decrease, p=0.0004), coincident with the peak in viral load
(Figure 1B). In agreement with our previous observations
[32], SIV-infection rapidly induced B-cell accumulation in
the intestinal mucosa as compared to controls (Figure 1C,
1D). However, the intensity of B-cell infiltration was vari-
able among SIV-infected animals and even at different sites
of the intestinal mucosa within one animal (Figure 1E and
1F). The median number of B-cell areas per μm2 of total
duodenal mucosa increased by 1.2-fold and 1.8-fold on 14
and 28 dpi, respectively (Figure 1E) whereas it increased by
1.1-fold and 1-fold in the terminal ileum, respectively
(Figure 1F). Despite high numbers of isolated B-cell follicles
in terminal ileum of SIV-infected animals, the concomitant
increase in mucosal thickness lowers the frequency value.
(Figure 1D, right panel). The development of GC within B-
cell follicles constitutes an independent marker of B-cell ac-
tivation. Within the intestinal mucosa of SIV-infected ani-
mals, B-cell follicles rapidly developed GC, with 39% of
duodenal follicles containing GC as compared to 3% in
controls. Whereas an average of 21% ileal B-cell areas con-
tained GC in controls, 34% and 44% of them contained GC
at 14 and 28 dpi, respectively.
These data evidence a consistent B-cell activation in in-
testinal mucosa during acute SIV infection, with an early
development of GC in intestinal B-cell follicles, which is in-
dicative of the initiation of TD B-cell response. However,
SIV-specific antibodies are only detectable in plasma from
21 dpi on in these animals [29].
Preferential increase in IgG plasma cells within GC during
acute SIV infection
Because CD20 expression is rapidly lost during terminal B-
cell differentiation, human plasma cells and their immediate
precursors are generally detected using CD19, CD38 and
CD138 mAb. While CD19 expression progressively
decreases, CD38 expression begins to be upregulated on
human plasmablasts and CD138 expression characterizes
late stages of plasma cell maturation [33]. The detection of
macaque B-cells engaged into terminal differentiation is
limited by the lack of suitable reagents: human CD19 and
human CD138 mAb possess limited and no cross-reactivity,
Figure 1 (See legend on next page.)
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Figure 1 Increased number of B-cell areas in the intestinal mucosa in acutely SIV-infected macaques. (A) For each of the 13 SIV-infected
macaques, viral load was measured in plasma before infection (Pre; filled circles) and every 3 dpi (open circles). Results are expressed as Log10
copies/mL and bars represent median values. (B) CD4+ T-cells were quantified in whole blood collected from each macaque before infection and
every 3 dpi. For each animal, CD4+ T-cell counts before infection (filled circles; n=13) and at 11-12 dpi (open circles, n=13) are shown. Results are
expressed as cells/μL and bars represent median values. *** p=0.0004 (Wilcoxon test) (C-D) Staining by CD20 mAb of sections from duodenum
(C) and terminal ileum (D) of one representative non-infected macaque (Ctl, n=3) and macaques infected for 14 (14 dpi, n=5) or 28 days (28 dpi,
n=3). Magnification x25 for all panels (E-F) The number of CD20+ B-cell areas per section was divided by the surface of the total mucosa. Results
are expressed as B-cell areas x 10-7/μm2. Each symbol corresponds to one animal. Bars represent median values for each group.
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criminate plasma cells from other simian B-cells subsets
(data not shown). We thus evaluated changes in plasma
cells by immunohistochemistry using alternative markers:
IRF4/MUM-1 and cytoplasmic Ig. High IRF4/MUM-1 pro-
tein expression is a hallmark of normal plasma cell differen-
tiation and a major marker of myeloma cells [34].
We found rare IgA plasma cells in GC of the duo-
denal mucosa of both control and SIV-infected maca-
ques. In contrast, total (stained by IRF4 mAb) and
IgG plasma cells per GC were 1.1- and 1.4-fold more
numerous in SIV-infected macaques on 28 dpi than
in controls (Figure 2A). In terminal ileum, the median
number of total plasma cells increased by 1.9- and
3.1-fold on 14 and 28 dpi, respectively. This increase
was essentially due to increased numbers of IgG
plasma cells per GC, with a 3.8- and 7.2-fold increase
on 14 and 28 dpi, respectively (Figure 2C). Therefore,
SIV-infection preferentially promotes an IgG response
within GC of the small intestine as in spleen and
mesenteric lymph nodes [32].SIV infection modifies the ratio of IgA versus IgM or IgG
plasma cells within the LP
Comparison between median values of each group
showed that densities in total plasma cells in the duo-
denal LP were 1.6- and 2.6-fold higher on 14 and 28 dpi,
respectively, than in controls (Figure 3A). However, a
variable increase in the density of each class-specific
plasma cells occurred on 14 and 28 dpi: 2.6- and 5.9-fold
increase for IgM plasma cells, 1.4- and 2.1-fold increase
for IgA, and 1.4- and 1.6-fold increase for IgG, respect-
ively (Figure 3B). Therefore, higher proportions of IgM
plasma cells were observed on 28 dpi (36% vs. 16% in
controls, 2.2-fold) at the expense of IgG (13% vs. 21% in
controls) and IgA (52% vs. 63% in controls) plasma cells
(Additional file 1: Figure S1A).
In the terminal ileum, the density of total plasma cells
also increased in the LP by 1.7- and 4.9-fold on 14 and 28
dpi as compared to controls (Figure 3C). As also compared
to controls, the density of IgA plasma cells increased by
1.4- and 3.1-fold on 14 and 28 dpi, that of IgG by 2.5- and
15-fold and that of IgM by 2.2- and 8.3-fold, respectively.These changes resulted in higher proportions of IgG
plasma cells at 28 dpi (21.5% vs. 7%) at the expense of IgA
plasma cells (43% vs. 66%) (Additional file 1: Figure S1B).
These data show that SIV-infection favors the generation of
IgM (duodenum) or IgG (ileum) rather than IgA plasma
cells in the LP of the small intestine.
Taken altogether these data suggest a biased isotype
class switching or an impaired survival of IgA plasma cells
in the intestinal mucosa of acutely SIV-infected macaques.Differential survival of CD4+ CD45RO+ T-cells in GC,
follicular T-cell zones and LP
We next examined T-cell changes in the LP and inductive
sites (PP and ILF) of the small intestine of SIV-infected
macaques. In the duodenum of control animals, we
observed numerous CD4+ (Figure 4B) and CD45RO+ T-
cells (recognized by the OPD4 clone) (Figure 4C,D) distrib-
uted throughout the LP as well as in follicular T-cell zones.
As compared to control macaques, CD45RO+ T-cell dens-
ity was 80% lower in the follicular T-cell zones at 14 dpi
(Figure 4F). The well-defined line of CD4+ and CD45RO+
T-cells, visible at the interface between mucosa and muscu-
laris mucosae in controls (Figure 4B, C, left panels, arrow)
was no more detectable in SIV-infected macaques, except
near and above B-cell follicles (Figure 4C, arrow); indeed
CD45RO+ T-cell density was decreased by 78% and 88% in
muscularis mucosae at 14 and 28 dpi, respectively
(Figure 4G). In contrast, the frequency of CD45RO+ T-cells
within the GC of duodenal B-cell follicles did not decrease
before 28 dpi (44% decrease) (Figure 4E). As shown by
CD23 and Ki67 staining, the polarization of GC was pre-
served until 28 dpi (Additional file 2: Figure S2).
In the terminal ileum, the median CD45RO+ T-cells
density decreased by 59% and 73% respectively at 14 and
28 dpi in follicular T-cell zones, and by 84% in muscularis
mucosae at 14 dpi, as compared to controls (data not
shown). Concomitantly, a 1.8-fold increase in CD45RO+ T-
cells was observed within the GC of ileal B-cell follicles on
14 dpi. Thus, in contrast to follicular T-cell zones and
muscularis mucosae where the depletion in CD4+ T-cells
rapidly progressed from 14 dpi on, CD4+ CD45RO+ T-cells
accumulated within GC of mucosal B-cell follicles at 14
dpi.
Figure 2 Acute SIV infection induces a dominant IgG/M over IgA response in GC. (A) Duodenal sections from controls (Ctl left panels) and
macaques infected for 28 days (28 dpi, right panels) were stained with IRF4 mAb, IgA, IgG and IgM polyclonal Ab. Staining of one representative
section for each group of macaques is shown. Magnification x200 and x1000 for enlarged images. (B-C) Each symbol represents the mean
number of IgA, IgG and IgM plasma cells per GC in duodenum (B) and terminal ileum (C) in one macaque. Bars represent median values for each
group.
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Figure 3 Acute SIV infection induces an increase in total
plasma cells in the intestinal LP with a dominant IgG/M over
IgA response. (A) Duodenal sections from controls (Ctl left panels)
and macaques infected for 28 days (28 dpi, right panels) were
stained with IRF4 mAb, IgA, IgG and IgM polyclonal Ab. Staining of
one representative section for each group of macaques is shown.
Magnification x200 and x1000 for enlarged images. (B, C) Each
symbol corresponds to the mean number of IgA, IgG and IgM
plasma cells in LP of duodenum (B) and terminal ileum (C) from one
macaque. Bars represent median values for each group. * p values
<0.05 (Mann–Whitney, one tailed).
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and LP
Because increased apoptosis might contribute to the
paucity of IgA plasma cells, we examined the expression of
the cleaved caspase-3, a key mediator of apoptosis shared
by membrane- and mitochondrial-mediated pathways. In
the duodenal mucosa, no cleaved caspase-3+ cells were
found within GC or follicular T-cell zones of control
macaques (data not shown). In the follicular T-cell zone,
the median density increased by 6.5-fold between 14 and
28 dpi (Figure 5A-F, 5 G) whereas the median number of
cleaved caspase-3+ cells is 10.5 and 3.2 cells/GC at 14 and
28 dpi, respectively (Figure 5H). In the terminal ileum, the
median density of apoptotic cells increased by 11-fold in
follicular T-cell zones and by only 1.7-fold in GC at 14 dpi,
as compared to controls (data not shown). These results
indicate that apoptosis progresses with different kinetics in
the inductive and effector mucosal compartments of SIV-
infected animals.
Decrease in plasma IgA despite increased BAFF
production
In contrast to increased plasma IgG and IgM levels
observed in these macaques prior to 14 dpi [32], plasma
IgA levels progressively decreased from 18% on 14 dpi to
46% on 28 dpi as compared to baseline values before in-
fection (Figure 6A). Considering that BAFF and APRIL
are important IgA inducing factors [13,35-37], we mea-
sured both of these cytokines in plasma. The median con-
centration of plasma APRIL, which was 22 ng/ml before
infection, varied between 13 and 18 ng/ml after SIV infec-
tion (Figure 6B). In contrast, we observed a sharp increase
in plasma BAFF that peaked at 11–12 dpi (1,347 pg/ml
versus 298 pg/ml before infection, 4.5-fold increase), and
remained elevated at 13–15 dpi (918 pg/ml, 3.1-fold in-
crease) and decreased toward baseline values thereafter
(Figure 6C). Throughout the acute phase of infection,
BAFF levels correlated with plasma viral load (p< 0.0001)
(Figure 6D) and inversely with circulating CD4+ T-cell
counts (rho=−0.596, p< 0.0001) but not with plasma IgA
(data not shown).
In an attempt to correlate increased plasma BAFF
levels with its local production in lymphoid tissues,
we compared BAFF expression in the intestinal mu-
cosa of acutely SIV-infected and control macaques
using Buffy2 mAb and immunohistochemical ap-
proach. Both isolated cells and stromal cell network
associated with B-cell follicles, and GC were strongly
stained by Buffy2 mAb (Figure 6E). The stromal net-
work in T-cell areas immediately adjacent to B-cell
follicles was also BAFF+. Our present results thus re-
veal increased BAFF production in intestinal mucosa
even if additional experiments in SIV-infected maca-
ques are needed to identify BAFF-producing cells in
Figure 4 Prolonged survival of CD4+CD45RO+T-cells in GC as compared to follicular T-cell zones and lamina propria. (A-D) Duodenal
sections from controls (Ctl) and macaques infected at 14dpi and 28dpi were stained with CD20 mAb (A), CD4 mAb (B), CD45RO mAb (C-D). In A
to D, data from one representative macaque per group are shown. Original magnification x100 for panels A to C, x200 for panel D. (E-G) Each
symbol corresponds to the mean density of CD45RO+ cells per μm2 of duodenal muscularis mucosae (MM, G), of follicular T-cell zone (F) and to
the mean number of CD45R0+ cells per GC (E) per macaque. Bars represent median values for each group. * p values <0.05 (Mann–Whitney).
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to quantify the magnitude of BAFF overproduction in
specific tissue areas. Thus, plasma IgA progressively
decreases during acute SIV infection despite increased
systemic and mucosal production of BAFF.
Discussion
Dysfunctions in circulating B-cells have been extensively
described in chronically, and to a lesser extent, in primary
HIV-infected patients [38-40]; but only very few studies
have been devoted to mucosal B-cells during primary HIV
infection [41]. This situation contrasts with the pivotal role
of the intestinal mucosa as a major site of IgA response in
healthy individuals as well as a site of intense and early
virus replication, heavy damages to CD4+ T-cell subsetsand chronic inflammation in HIV-infected individuals.
Consistent with early inflammation described in pathogenic
SIV/HIV infection, we observed overproduction of BAFF
and infiltration of the intestinal mucosa by isolated lymph-
oid follicles, which progressively organized into secondary
follicles containing well-developed GC (32 and this work).
This increase in B-cell areas is consistent with increased
proportions of B-cells within the ileal LP of primary HIV-
infected patients reported by Levesque et al. [41]. In
addition to PP, isolated lymphoid follicles constitute import-
ant sites for the IgA response against bacteria and are also
associated with chronic inflammation in several disorders
[42,43]. As previously observed in mesenteric lymph nodes
of the same animals [32], a dominant IgG over IgA re-
sponse was observed in GC of both PP and isolated
Figure 5 Apoptosis progresses more rapidly in LP than in GC. (A-F) Duodenal sections from one representative macaque at 14 dpi and 28
dpi were stained with anti-cleaved caspase-3 Ab (A-F). Inserts from left panels are shown in middle (B and E; showing GC) and right panels (C
and F; showing follicular T-cell zones). Original magnification x100 in left panels and x400 in middle and right panels. (G-H) Each symbol
corresponds to the mean density of cleaved caspase3+ cells per μm2 of follicular T-cell Zone (G) and to the mean number of cleaved caspase-3+
cells per GC (H) per macaque. Bars represent median values for each group. *p value< 0.05 (Mann–Whitney).
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blasts in these GC that display a preserved polarization
([32] and Additional file 2: Figure S2) is in favor offunctional GC, which nevertheless have lost the capacity to
support T-dependent IgA response. In SIV-infected maca-
ques, normal expression of Bcl6 and Ki67 by GC B-cells
Figure 6 Decreased plasma IgA levels despite a strong increase in BAFF levels. (A) Plasma IgA levels were measured in SIV-infected
macaques before infection (Pre; filled diamonds) and every 7 dpi (open circles). Results are expressed in mg/mL and bars represent median levels.
Significant differences between groups are shown (*p< 0.05). (B-C) APRIL and BAFF levels were measured in plasma from SIV-infected macaques,
before (Pre: filled diamonds) and every 3 dpi (open circles). Results are expressed in pg/mL (BAFF) and ng/mL (APRIL), and bars represent median
levels. Significant differences between groups are shown (*p< 0.05, **p< 0.01). (D) Correlation between BAFF levels and plasma viral load (Log10
pVL) is shown. (E) Ileum sections from control macaques (upper panel) and macaques infected for 14 days (lower panel) were stained with anti-
CD20 (B-cells, left panels) or anti-BAFF (Buffy2, middle and right panels) mAb. Original magnification: x200 for CD20, x100 and x400 for Buffy2.
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duction of IL21 by follicular helper T-cells is likely not re-
sponsible for the lack of IgA plasma cells. The expression
of these factors is under the control of IL21-IL21R interac-
tions [5,44]. Because most systemic IgA are of T-dependent
origin, the marked decrease in plasma IgA levels isconsistent with the absence of IgA plasmablasts within GC.
However, the precise mechanism underlying their absence
within functional GC remains to be further investigated.
As compared to their accelerated death in LP and follicu-
lar T-cell zones, CD4+ CD45RO+ T-cells were present
within GC until 28 dpi, suggesting a prolonged survival
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related to the low CCR5 expression on follicular helper T-
cells, which might protect them from SIV infection [45]. A
less dramatic loss of CD4+ T-cells in PP than in LP has
been previously reported in SIV-infected monkeys [2,46].
Moreover, Zhang et al. have shown that early GC disrup-
tion (20 dpi) occurs preferentially after SIV infection of In-
dian rhesus monkeys, a model of rapid disease progression
[47]. Aside from the results of Levesque et al. showing GC
fragmentation in primary HIV-infected patients [39], invo-
lution of GC is more frequent during chronic and advanced
phases of the disease when CXCR4 variants are present
[31,48]. However, treatment of HIV-infected patients with
CCR5 antagonists has shown that small populations of X4
variants are more frequently present during primary HIV
infection than previously suspected [49]. When present,
these variants might contribute to the infection of follicular
helper T-cells expressing CXCR4 and, hence, to their apop-
tosis [45].
Because of the presence of follicular helper T-cells and
appropriate GC organization, other mechanisms could ac-
count for the lack of T-dependent IgA response within GC.
Among other possibilities, a decreased production of active
TGFβ1 or retinoic acids associated with impaired activation
of intestinal dendritic cells might reduce the IgA response
[50,51]. Interestingly, differential kinetics of TGFβ1 produc-
tion and responsiveness to TGFβ1 distinguish pathogenic
from non-pathogenic SIV infections [52,53]. The frequency
of TGFβ-positive cells also increases in the peripheral or
mesenteric lymph nodes of SIVmac-infected rhesus maca-
ques but not in those of African green monkeys or sooty
mangabeys [54,55]. Even in acutely SIVmac-infected maca-
ques where TGFβ+ cells accumulate in paracortical T-cell
zones of lymph nodes with a peak at 11-16dpi, these cells
were absent from GC of B-cell follicles. Whether the lack
of TGFβ+ cells reflects impaired T-cell production in SIV-
infected animals or normal low levels of TGF within GC
remains to be clarified. In addition, the absence of newly
generated IgA plasmablasts at the benefit of IgG and IgM
ones as well as the rapid loss of CD4+ T-cells within the LP,
likely participates to decrease the proportions of IgA
plasma cells in this effector site.Conclusion
Our data point to a generalized default in IgA response,
already detectable during the acute phase of infection.
The understanding of mechanisms causing this impaired
IgA response during HIV/SIV infection is crucial in order
to improve the mucosal virus-specific response and con-
trol microbial translocation. Considering the importance
of mucosal defenses in determining the host-pathogen
balanced relationship [56-58], it remains to be established
whether the early default in the T-dependent IgA responsesimilarly occurs after infection by mucosal routes which
represent the more frequent routes of HIV infection.
Methods
Animals and ethics statement
Mauritian adult male Cynomolgus macaques (Macaca
fascicularis), weighing 4 to 6 kg, were housed each in
single cages within level 3 biosafety facilities. Animals
were housed and cared for in accordance with the Euro-
pean Guidelines for Animal Care (“Journal officiel des
Communautés Européennes” L358, 18 décembre 1986).
A regional Animal Care and Use Committee: “Comité
Régional d’Ethique sur l’expérimentation animale Ile-de-
France Sud”, reviewed and approved all protocols, with
the goal of improving animal welfare and limiting un-
necessary suffering. The animals were sedated with Keta-
mine chlorydrate (Rhone-Merieux, Lyon, France) before
virus injection, blood sample collection or euthanasia.
The animals were inoculated intravenously with 50
AID50 SIVmac251 and were euthanized at 14 (five ani-
mals), 21 (five animals) and 28 (three animals) days
post-infection (dpi). Blood samples were collected before
infection and every 3 dpi thereafter until euthanasia.
Plasma samples were kept at −80°C until use. Changes
in plasma viral load, CD4+ T-cell counts, circulating and
tissue-specific B-cell subsets of these SIV-infected maca-
ques have been previously reported [32]. After euthan-
asia, duodenal and terminal ileum tissue samples
(corresponding to a five cm section before the caecum)
were formalin-fixed and paraffin-embedded. Control tis-
sues were collected from three non-infected animals.
Quantification of immunoglobulin A and cytokines
Plasma BAFF and APRIL levels were respectively quanti-
fied using the Quantikine® ELISA kit for human BAFF/
BLyS (R&D systems, Abingdon, UK) and APRIL human
ELISA from Bender Medsystems (Tebu-Bio, Le Perray
en Yvelines, France) according to the manufacturer’s
instructions. Plasma IgA concentrations were deter-
mined using a monkey IgA ELISA kit (Alpha diagnostic
Intl Inc., San Antonio, Tx). Each sample was run in du-
plicate and results expressed as mean concentration (pg/
mL for BAFF, ng/mL for APRIL and mg/ml for IgA) ±
SD for each animal and at each time point.
Immunohistochemistry (IHC) and image analysis
All paraffin-embedded tissues were cut into (3 μm) sec-
tions, perpendicularly to the intestinal wall so that each
intestinal compartment could be examined. After antigen
retrieval in sodium citrate (pH6) (CD20, Ki67, Buffy2),
EDTA (pH 9) (CD3) or EDTA (pH 8) (other Ab), sections
were then labeled with optimized concentrations of
monoclonal or polyclonal antibodies against: CD20 (L26),
IRF4 (MUM-1P), IgA (rabbit F(ab’)2, IgG (rabbit F(ab’)2,
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KP1) (all from Dako, Glosturp, Danemark), CD4 (1 F6)
and CD23 (1B12) (from Novocastra, Newcastle, UK), Ki67
(MIB5, Beckman Coulter, Fullerton), CD3 (SP34-2, Becton
Dickinson, Franklin Lakes, NJ) and cleaved caspase-3
(rabbit serum, Cell Signaling Technology Inc., Danvers,
MA). Polyclonal Ig and mouse isotype controls were from
Dako or R&D systems. Antibody binding was visualized
with the Novolink anti-rabbit/mouse secondary Ab
Polymer kit (Novocastra Laboratories, Newcastle upon
Tyne, UK) according to the manufacturer’s instructions.
Binding of Buffy2 mAb (Enzo life Sciences, Villeurbanne,
France) was visualized by the EnVision™ +Dual Link Kit
from Dako. Nuclei were counter-stained with
Hematoxylin QS (Vector Laboratories, Burlingame, CA).
Digital images of tissue sections were captured without
manipulation using a Zeiss Microscope (Axiophot 2)
coupled to a Microfire camera (Optronics, CA) and using
the MorphoLite software (Explora Nova, La Rochelle,
France).
Image analysis was performed with the Mercator 4.42
software (Explora Nova) on tissue sections from three non-
infected animals as controls and from SIV-infected animals
euthanized at either 14 or 28 dpi. Epithelium was outlined
by hand and excluded in each field. Area from muscularis
mucosae to tips of villi was referred to as “total mucosa”
whereas CD3+ T-cell areas surrounding B-cell areas, includ-
ing isolated lymphoid follicles and B-cell follicles in PP,
were referred to as “follicular T-cell zones” throughout the
manuscript. The LP was defined as total mucosa minus fol-
licular T-cell zones and B-cell areas. The number of B-cell
areas was determined by counting CD20+ areas in total
mucosa at 100X magnification, corresponding to surface
areas of 9,467 to 308,392 (duodenum) and 8,000 to 12,409
(ileum) μm2. Data are expressed as the average number of
B-cell areas per μm2 of total mucosa. Immunoreactive cells
were counted in all GC present in every section at 100X
magnification. By using the Novolink anti-rabbit/mouse
secondary Ab Polymer kit, we experienced limited difficul-
ties in discriminating Ig-producing cells from the reticular
background possibly observed in GC or sub-epithelial
areas. Accordingly, only cells with a clear cytoplasmic stain-
ing were taken into account for quantification. Data are
expressed as mean (±SD) number of positive cells per GC.
Immunoreactive cells were counted in follicular T-cell
zones, muscularis mucosae (MM) or LP by analyzing as
many fields as possible at 100X magnification. Surface areas
of 7,900 to 112,172 (duodenum) and 6,167 to 161,140
(ileum) μm2 for follicular T-cell zones; 1,182 to 71,742
(duodenum) and 29,000 to 51,500 (ileum) μm2 for muscu-
laris mucosae; 147,000 to 900,000 (duodenum) and 235,000
to 750,000 (Ileum) μm2 for LP were analyzed. Data are
expressed as the mean density of immunoreactive cells
(number of positive cells (±SD)/μm2).Statistical analyses
Non-parametric Wilcoxon‘s test or Mann-Whitney’s test
(two-tailed unless otherwise indicated) and correlations
(Spearman’s rank test) were assessed using the GraphPad
Prism 5 software (La Jolla, CA). p values< 0.05 were con-
sidered as significant.
Additional files
Additional file 1: Figure S1. Acute SIV-Infection changes the density
of IgA, IgG and igM plasma cells in the intestinal LP. The relative
proportions of IgA, IgG and IgM plasma cells in the LP of duodenum (A)
or ileum (B) were calculated, for each group of macaques, as the ratio
between the median numbers of positive cells for one isotype to the
median number of total plasma cells X100.
Additional file 2: Figure S2. Preserved polarization of GC in SIV-
infected macaques. (A-D) Duodenum sections from controls (Ctl; left
panel) and macaques infected for 14 dpi (middle panel) and 28 dpi (right
panel) were stained with CD20 (A), CD23 (B), Ki67 (C) and CD68 (D) Ab.
Stained sections from one representative macaque per group are shown.
Original magnification: x100 for all panels. Because T-dependent response
is strongly dependent on GC, we analyzed the GC organization after SIV
infection. CD23 mAb strongly stains mature FDC network of the light
zone, while Ki67 Ab stains proliferating B-cells present in the dark zone
and helper T-cells in the light zone. ILF without GC in the duodenal
mucosa of controls were stained by CD20 mAb (A) but not by Ki67 mAb
(C). In the absence of typical GC-like structures, CD23 mAb consistently
stained the network of stromal cells in these ILF (B). After SIV-infection,
GC progressively developed in B-cell follicles with numerous Ki67+ cells
on 14 dpi and a strong staining of a patchy FDC network. On 28 dpi, GCs
were clearly hyperplasic but still correctly polarized as shown by Ki67
staining (C). The increase in Ki67+ cells (B-cells and helper T-cells) within
the GC in SIV-infected macaques was concomitant with T-cell activation
in the LP and T-cell zones. Whereas rare CD68+ macrophages were
present within B-cell follicles in controls, they were consistently present
in GC at 14 and 28 dpi. We observed similar changes for CD23 and Ki67
staining in terminal ileum (data not shown).
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